Insider Transactions Reported by 20 Insiders of Pyxis Oncology, Inc.

Symbol
PYXS on Nasdaq
Location
Boston, MA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Pyxis Oncology, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
PFIZER INC 10%+ Owner $19,410,445 17 Mar 2023
Pamela Ann Connealy Cfo & Coo $4,987,686 31 Mar 2025
BARCLAYS PLC 10%+ Owner $4,869,165 26 Apr 2022
Bayer World Investments B.V. Former 10% Owner $3,839,273 13 Oct 2021
Cormorant Asset Management, LP Former 10% Owner $1,566,396 13 Oct 2021
Jay Feingold Chief Medical Officer $1,089,573 24 Mar 2023
Lara Sullivan President ,CEO & CMO, Director $899,942 31 Mar 2025
Ken Kobayashi Chief Medical Officer $424,663 29 Dec 2023
Jitendra Wadhane SVP, Chief Accounting Officer $258,506 31 Mar 2025
Ronald Herbst Chief Scientific Officer $234,796 07 Oct 2021
Ritu Shah Chief Operating Officer $120,048 07 Oct 2021
Santhosh Palani Director $47,999 31 Mar 2025
John L. Flavin Director $36,239 31 Mar 2025
Michael A. Metzger Director $36,239 31 Mar 2025
Thomas Civik Interim CEO, Director $36,239 03 Feb 2026
Jakob Dupont Director $36,239 31 Mar 2025
Darren S. Cline Director $36,239 31 Mar 2025
Freda Lewis-Hall Director $36,239 31 Mar 2025
Rachel Humphrey Director $36,239 31 Mar 2025
Mark Chin Former Director 21 Apr 2022

Recent Insider Transactions by Companies or Individuals for Pyxis Oncology, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Thomas Civik PYXS Stock Option (Right to Buy) Award 690,131 690,131 03 Feb 2026 Direct
Lara Sullivan PYXS Stock Option (Right to Buy) Award 918,308 918,308 31 Mar 2025 Direct
Michael A. Metzger PYXS Stock Option (Right to Buy) Award 36,979 36,979 31 Mar 2025 Direct
Jitendra Wadhane PYXS Stock Option (Right to Buy) Award 263,782 263,782 31 Mar 2025 Direct
Rachel Humphrey PYXS Stock Option (Right to Buy) Award 36,979 36,979 31 Mar 2025 Direct
Freda Lewis-Hall PYXS Stock Option (Right to Buy) Award 36,979 36,979 31 Mar 2025 Direct
Darren S. Cline PYXS Stock Option (Right to Buy) Award 36,979 36,979 31 Mar 2025 Direct
Jakob Dupont PYXS Stock Option (Right to Buy) Award 36,979 36,979 31 Mar 2025 Direct
Santhosh Palani PYXS Stock Option (Right to Buy) Award 36,979 36,979 31 Mar 2025 Direct
Thomas Civik PYXS Stock Option (Right to Buy) Award 36,979 36,979 31 Mar 2025 Direct
Pamela Ann Connealy PYXS Stock Option (Right to Buy) Award 414,163 414,163 31 Mar 2025 Direct
John L. Flavin PYXS Stock Option (Right to Buy) Award 36,979 36,979 31 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.